BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35115664)

  • 41. Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysis.
    Li ML; Xu WW; Gao YD; Guo Y; Wang WJ; Wang C; Jiang SY; Willden A; Huang JF; Zhang HT
    PLoS One; 2013; 8(3):e60048. PubMed ID: 23555878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.
    Onabajo OO; Muchmore B; Prokunina-Olsson L
    J Interferon Cytokine Res; 2019 Oct; 39(10):636-641. PubMed ID: 31241411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
    J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.
    Popēna I; Ābols A; Saulīte L; Pleiko K; Zandberga E; Jēkabsons K; Endzeliņš E; Llorente A; Linē A; Riekstiņa U
    Cell Commun Signal; 2018 Apr; 16(1):17. PubMed ID: 29690889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infection by bovine alphaherpesvirus types 1 and 5 induces IFN-λ3 expression in neuronal-type cells and bovine neural tissues.
    Rosales JJ; Nieto Farías MV; Burucúa M; Marin MS; Pérez SE
    Vet Immunol Immunopathol; 2022 Mar; 245():110391. PubMed ID: 35114600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
    Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
    Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Soluble expression and one-step purification of recombinant mouse interferon-λ3 in Escherichia coli.
    Wang YQ; Zhou M; Zeng LM; Gao QY; Yuan XL; Li Y; Li MC
    Biochemistry (Mosc); 2015 Feb; 80(2):228-32. PubMed ID: 25756537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis.
    Read SA; Gloss BS; Liddle C; George J; Ahlenstiel G
    J Inflamm Res; 2021; 14():1257-1270. PubMed ID: 33833547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin 27 as an inducer of antiviral response against chikungunya virus infection in human macrophages.
    Valdés-López JF; Fernandez GJ; Urcuqui-Inchima S
    Cell Immunol; 2021 Sep; 367():104411. PubMed ID: 34325085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type III Interferons in Systemic Lupus Erythematosus: Association Between Interferon λ3, Disease Activity, and Anti-Ro/SSA Antibodies.
    Amezcua-Guerra LM; Márquez-Velasco R; Chávez-Rueda AK; Castillo-Martínez D; Massó F; Páez A; Colín-Fuentes J; Bojalil R
    J Clin Rheumatol; 2017 Oct; 23(7):368-375. PubMed ID: 28937472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza A virus replication is inhibited in IFN-λ2 and IFN-λ3 transfected or stimulated cells.
    Svetlikova D; Kabat P; Ohradanova A; Pastorek J; Betakova T
    Antiviral Res; 2010 Dec; 88(3):329-33. PubMed ID: 20969894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons.
    Osterlund P; Pirhonen J; Ikonen N; Rönkkö E; Strengell M; Mäkelä SM; Broman M; Hamming OJ; Hartmann R; Ziegler T; Julkunen I
    J Virol; 2010 Feb; 84(3):1414-22. PubMed ID: 19939920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.
    Murata K; Sugiyama M; Kimura T; Yoshio S; Kanto T; Kirikae I; Saito H; Aoki Y; Hiramine S; Matsui T; Ito K; Korenaga M; Imamura M; Masaki N; Mizokami M
    J Gastroenterol; 2014 Jan; 49(1):126-37. PubMed ID: 23591768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells.
    Makjaroen J; Somparn P; Hodge K; Poomipak W; Hirankarn N; Pisitkun T
    Mol Cell Proteomics; 2018 Nov; 17(11):2197-2215. PubMed ID: 30097535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact and regulation of lambda interferon response in human metapneumovirus infection.
    Baños-Lara Mdel R; Harvey L; Mendoza A; Simms D; Chouljenko VN; Wakamatsu N; Kousoulas KG; Guerrero-Plata A
    J Virol; 2015 Jan; 89(1):730-42. PubMed ID: 25355870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IFN-λ3 as a host immune response in acute hepatitis E virus infection.
    Murata K; Kang JH; Nagashima S; Matsui T; Karino Y; Yamamoto Y; Atarashi T; Oohara M; Uebayashi M; Sakata H; Matsubayashi K; Takahashi K; Arai M; Mishiro S; Sugiyama M; Mizokami M; Okamoto H
    Cytokine; 2020 Jan; 125():154816. PubMed ID: 31465972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.
    Chinnaswamy S
    Genes Immun; 2016 Jul; 17(5):265-75. PubMed ID: 27278127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells.
    Onabajo OO; Porter-Gill P; Paquin A; Rao N; Liu L; Tang W; Brand N; Prokunina-Olsson L
    J Interferon Cytokine Res; 2015 Nov; 35(11):888-900. PubMed ID: 26134097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro.
    Nielsen MC; Andersen MN; Møller HJ
    Immunology; 2020 Jan; 159(1):63-74. PubMed ID: 31573680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study.
    Bruno S; Thompson AJ; Critelli R; Crosignani A; Rossi S; De Lisi S; Cariani E; Zermiani P; Vaira V; Boccaccio V; Maisonneuve P; Villa E
    Antiviral Res; 2015 Jan; 113():27-32. PubMed ID: 25446338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.